Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | SCD | O00767 | 1/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.35 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.34 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
| ▸ | NR3C2 | P08235 | 4/20 | 0.33 |
| ▸ | PGR | P06401 | 2/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3488781 | 0.81 | MAPT (0.38) | MAPTALDH1A1SLC34A1SLC2A1NR3C2 | |
| SCHEMBL3488754 | 0.79 | L3MBTL1 (0.47) | MAPTALDH1A1NR3C2PGRNR1H2 | |
| SCHEMBL3488703 | 0.79 | ALDH1A1 (0.41) | MAPTALDH1A1SLC34A1SLC2A1NR3C2 | |
| SCHEMBL3489982 | 0.79 | SLC2A1 (0.54) | MAPTSLC2A1NR3C2PGRNR1H2 | |
| SCHEMBL3489611 | 0.76 | MAPT (0.52) | MAPTALDH1A1SLC34A1SLC2A1NR3C2 | |
| SCHEMBL3489954 | 0.76 | MAPT (0.39) | MAPTALDH1A1GRIN1GRIN2BSLC34A1 | |
| SCHEMBL3488088 | 0.76 | SLC2A1 (0.50) | MAPTALDH1A1SLC2A1NR3C2PGR | |
| SCHEMBL3488270 | 0.76 | PGR (0.49) | MAPTALDH1A1SLC2A1NR3C2PGR | |
| SCHEMBL3488787 | 0.74 | NR3C2 (0.50) | MAPTSLC2A1NR3C2PGRNR1H2 | |
| SCHEMBL3489605 | 0.74 | SLC2A1 (0.40) | MAPTALDH1A1SLC2A1NR3C2PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100094000-A1 | PYRAZOLE COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-04-15 | — | — | US | disclosed |
| US-20100094000-A1 | PYRAZOLE COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-04-15 | — | — | US | disclosed |
| US-20100094000-A1 | PYRAZOLE COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100094000-A1 | PYRAZOLE COMPOUNDS | NR3C2, MC2R, NR3C1 | MAPT 2903/4885ALDH1A1 1704/4885SCD 4340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.